×

Healthcare

USD Analytics healthcare data solutions deliver information, analytics, and solutions for the world's major medical device, pharmaceutical companies, financial markets, and governments. The company leverages its vast databases and industry expertise to present in-depth and up-to-date analyses of healthcare industries. The solution enables users to make efficient and informed decisions across the market. The Global Healthcare markets service presents an analysis of 60 countries with an updated outlook for the pharmaceutical industry. The reports in the service are updated every month and present healthcare expenditure, pharmaceutical sales, pharmaceutical goods trade balance, population forecasts, life expectancy, Consumer Price Inflation, GDP forecast, regulatory analysis, and company profiles. The Pipeline, Epidemiology, and Disease Market Outlook service presents disease pipeline reviews, clinical trial analysis, epidemiology reports, and disease market outlook for over 300 conditions. In addition, Analysis of marketed drugs, upcoming drug candidates, and other information is included in the research solutions. Further, the market size outlook and competitive analysis of medical devices, Healthcare IT, Analytics and Instrumentation, and the Biotechnology industry outlook are analyzed.

Healthcare
Chemical Report Listings

Gene Expression Analysis Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product & Service (Reagents & Consumables, Instruments, Service), By Application (Drug Discovery & Development, Clinical Diagnostics, Others), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others), Countries and Companies Report

Gene Expression Analysis Market is projected to register a 7.4% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00023118  |   No. of Pages: 208

Companion Animal Diagnostics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Technology (Immunodiagnostics, Clinical Biochemistry, Hematology, Urinalysis, Molecular Diagnostics, Others), By Application (Clinical Pathology, Bacteriology, Virology, Parasitology, Others), By Animal (Dog, Cat, Horse, Others), By End-User (Diagnostics Laboratories, Veterinary Clinics, Hospitals, Research Institute, Others), Countries and Companies Report

Companion Animal Diagnostics is projected to register a 7.7% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: November, 2024  |   Report Code: USD00024178  |   No. of Pages: 205

Cerebro spinal Fluid Management Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (CSF shunts, External drainage system), By Age Group (Pediatric, Adult), Countries and Companies Report

Cerebro spinal Fluid Management is projected to register a 5.3% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: November, 2024  |   Report Code: USD00024167  |   No. of Pages: 205

Transcranial Magnetic Stimulation System Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Deep Transcranial Magnetic Stimulator, Repetitive Transcranial Magnetic Stimulator, Others), By Application (Alzheimer’s Disease, Depression, Parkinson’s Disease, Epilepsy, Others), By Age group (Adults, Children), Countries and Companies Report

Transcranial Magnetic Stimulation System Market is projected to register a 10.2% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD000437  |   No. of Pages: 189

Type 1 Diabetes Drugs Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Insulin Group (Long-acting, Rapid-acting, Regular or short-acting, Intermediate-acting), By Type (Insulins, Symlin), By Intake Duration (Split or mixed, Split or mixed variant, Multiple daily injections (MDI), Continuous subcutaneous insulin infusion (CSII)), Countries and Companies Report

Type 1 Diabetes Drugs Market is projected to register a 6.7% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00022968  |   No. of Pages: 196

Alpha Emitter Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Diagnostic Products (SPECT (TC-99m, TL-201, GA-67, I-123, Others), PET (F-18, SR-82/RB-82, Others), By Therapeutic Products (Alpha Emitters (RA-223, Others), Beta Emitters (I-131, Y-90, SM-153, Re-186, Lu-117 , Others), Brachytherapy (Cesium-131,Iodine-125,Palladium-103, Iridium-192, Others), By Application (Cardiology, Neurology, Oncology, Thyroid, Lymphoma, Bone Metastasis, Endocrine Tumor, Others), By End-user ( Hospitals & Clinics, Diagnostic Centers, Others), Countries and Companies Report

Alpha Emitter Market is projected to register a 12.2% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00012007  |   No. of Pages: 195

Surgical Display Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Low-end, Mid-end, High-end), Countries and Companies Report

Surgical Display Market is projected to register a 3.2% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD000771  |   No. of Pages: 192

Tyrosine Kinase Inhibitors Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (BCR-ABL Tyrosine Kinase Inhibitor, Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors, Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitors, Others), By Application (Chronic Myeloid Leukemia (CML), Lung Cancer, Breast Cancer, Renal Cell Cancer, Others), Countries and Companies Report

Tyrosine Kinase Inhibitors Market is projected to register a 8.6% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00022970  |   No. of Pages: 191

Oral Antidiabetic Drugs Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Drug (Biguanides, Alpha-glucosidase inhibitors, Dopamine -D2 Receptor Agonist, Sodium-glucose Cotransport -2 (SGLT-2) inhibitor, Dipeptidyl Peptidase - 4 (DPP-4) Inhibitors, Sulfonylureas, Meglitinides), Countries and Companies Report

Oral Antidiabetic Drugs is projected to register a 5.3% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: November, 2024  |   Report Code: USD0009498  |   No. of Pages: 205

Cell Culture Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Consumables, Instruments), By Application (Biopharmaceutical Production, Drug Development, Diagnostics, Tissue Culture & Engineering, Cell and Gene Therapy, Toxicity Testing, Others), Countries and Companies Report

Cell Culture is projected to register a 12.8% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: November, 2024  |   Report Code: USD00024155  |   No. of Pages: 205